February 19, 2026
New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.
September 24, 2025
The 48th annual scientific symposium featured lively talks on cancer discovery and application, marked the kickoff of UNC Lineberger’s 50th anniversary as an NCI-designated cancer center, and celebrated Shelley Earp, MD, for his leadership at UNC and nationally.
May 1, 2024
Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma that will be key to the development of new drugs to treat the disease.
February 14, 2023
What started as a shared passion for science grew into love for UNC Lineberger virologists Blossom Damania, PhD, and Dirk Dittmer, PhD, whose bond is continually strengthened through their commitment to research.
February 6, 2023
A study led by researchers in the lab of Blossom Damania, PhD, shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus evade innate immune detection to spread undeterred.
October 18, 2022
February 7, 2022
Blossom Damania, PhD, and Dirk Dittmer, PhD, are being recognized individually for their expertise in cancer virology and global oncology, and their service to the university and state.
June 7, 2021
Expertscape rated 12 UNC Lineberger faculty members as top-rated experts in their fields for its 2021 rankings.
May 11, 2021
The University of North Carolina at Chapel Hill is recognizing 118 UNC Lineberger staff and faculty members who will be celebrating a service milestone this year.
August 25, 2020
A team of UNC researchers are partnering with colleagues at three institutions in Africa to study HIV-associated malignancies: Kaposi sarcoma, cervical cancer and lymphoma.